These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 34851165

  • 1. pmrCAB Recombination Events among Colistin-Susceptible and -Resistant Acinetobacter baumannii Clinical Isolates Belonging to International Clone 7.
    Nodari CS, Fuchs SA, Xanthopoulou K, Cayô R, Seifert H, Gales AC, Dilthey A, Higgins PG.
    mSphere; 2021 Dec 22; 6(6):e0074621. PubMed ID: 34851165
    [Abstract] [Full Text] [Related]

  • 2. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Gerson S, Lucaßen K, Wille J, Nodari CS, Stefanik D, Nowak J, Wille T, Betts JW, Roca I, Vila J, Cisneros JM, Seifert H, Higgins PG.
    Int J Antimicrob Agents; 2020 Mar 22; 55(3):105862. PubMed ID: 31837449
    [Abstract] [Full Text] [Related]

  • 3. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V, Gartenmann S, Tötzl M, Lucchini V, Schellhorn B, Pieren M, Lociuro S, Gitzinger M, Tigges M, Bumann D, Kemmer C.
    mBio; 2019 Jul 16; 10(4):. PubMed ID: 31311879
    [Abstract] [Full Text] [Related]

  • 4. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E, Gómez-Gil R, Sanz S, González-Zorn B, Daoud Z, Mingorance J, Suárez M.
    Int J Antimicrob Agents; 2017 Jun 16; 49(6):727-733. PubMed ID: 28438568
    [Abstract] [Full Text] [Related]

  • 5. PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
    Lunha K, Thet KT, Ngudsuntia A, Charoensri N, Lulitanond A, Tavichakorntrakool R, Wonglakorn L, Faksri K, Chanawong A.
    Infect Genet Evol; 2020 Nov 16; 85():104577. PubMed ID: 33007498
    [Abstract] [Full Text] [Related]

  • 6. Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons.
    Zafer MM, Hussein AFA, Al-Agamy MH, Radwan HH, Hamed SM.
    Front Cell Infect Microbiol; 2023 Nov 16; 13():1229473. PubMed ID: 37600939
    [Abstract] [Full Text] [Related]

  • 7. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E, Yoon EJ, McGann P, Snesrud E, Kwak Y, Milillo M, Onmus-Leone F, Preston L, St Clair K, Nikolich M, Viscount H, Wortmann G, Zapor M, Grillot-Courvalin C, Courvalin P, Clifford R, Waterman PE.
    J Infect Dis; 2013 Oct 01; 208(7):1142-51. PubMed ID: 23812239
    [Abstract] [Full Text] [Related]

  • 8. Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.
    Pournaras S, Poulou A, Dafopoulou K, Chabane YN, Kristo I, Makris D, Hardouin J, Cosette P, Tsakris A, Dé E.
    Antimicrob Agents Chemother; 2014 Oct 01; 58(2):828-32. PubMed ID: 24247145
    [Abstract] [Full Text] [Related]

  • 9. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M, Kafshdouz M, Feizabadi MM.
    Microb Drug Resist; 2018 Nov 01; 24(9):1271-1276. PubMed ID: 29590004
    [Abstract] [Full Text] [Related]

  • 10. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D, Elzayat MG, Diab AA, El-Shqanqery HE, Samir O, Bakry U, Hassan R, Elanany M, Shalaby L, Sayed AA.
    mSphere; 2021 Dec 22; 6(6):e0072521. PubMed ID: 34787450
    [Abstract] [Full Text] [Related]

  • 11. A distinct alleles and genetic recombination of pmrCAB operon in species of Acinetobacter baumannii complex isolates.
    Kim DH, Ko KS.
    Diagn Microbiol Infect Dis; 2015 Jul 22; 82(3):183-8. PubMed ID: 25934155
    [Abstract] [Full Text] [Related]

  • 12. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Vijayakumar S, Swetha RG, Bakthavatchalam YD, Vasudevan K, Abirami Shankar B, Kirubananthan A, Walia K, Ramaiah S, Biswas I, Veeraraghavan B, Anbarasu A.
    Microbiol Spectr; 2024 Feb 06; 12(2):e0251123. PubMed ID: 38214512
    [Abstract] [Full Text] [Related]

  • 13. Promoters of Colistin Resistance in Acinetobacter baumannii Infections.
    Nurtop E, Bayındır Bilman F, Menekse S, Kurt Azap O, Gönen M, Ergonul O, Can F.
    Microb Drug Resist; 2019 Sep 06; 25(7):997-1002. PubMed ID: 30964377
    [Abstract] [Full Text] [Related]

  • 14. The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii.
    Seleim SM, Mostafa MS, Ouda NH, Shash RY.
    Sci Rep; 2022 Dec 05; 12(1):20951. PubMed ID: 36470921
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC.
    Microb Pathog; 2019 Mar 05; 128():75-81. PubMed ID: 30562602
    [Abstract] [Full Text] [Related]

  • 16. ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin.
    Potron A, Vuillemenot JB, Puja H, Triponney P, Bour M, Valot B, Amara M, Cavalié L, Bernard C, Parmeland L, Reibel F, Larrouy-Maumus G, Dortet L, Bonnin RA, Plésiat P.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2544-2550. PubMed ID: 31199431
    [Abstract] [Full Text] [Related]

  • 17. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y, Bae IK, Jeong SH, Yong D, Lee K.
    Yonsei Med J; 2015 Jul 01; 56(4):928-34. PubMed ID: 26069113
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity and Genomic Plasticity of Acinetobacter baumannii and Acinetobacter nosocomialis Isolates Recovered from Clinical Samples in India.
    Tantry M, Shaw T, Rao S, Mukhopadhyay C, Tellapragada C, Kalwaje Eshwara V.
    Curr Microbiol; 2024 Oct 19; 81(12):415. PubMed ID: 39425793
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe.
    Goic-Barisic I, Music MS, Drcelic M, Tuncbilek S, Akca G, Jakovac S, Tonkić M, Hrenovic J.
    J Glob Antimicrob Resist; 2023 Jun 19; 33():26-30. PubMed ID: 36878462
    [Abstract] [Full Text] [Related]

  • 20. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
    Leite GC, Stabler RA, Neves P, Perdigão Neto LV, Ruedas Martins RC, Rizek C, Rossi F, Levin AS, Costa SF.
    Diagn Microbiol Infect Dis; 2019 Sep 19; 95(1):99-101. PubMed ID: 31178071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.